(Q35897375)

11 August 2017

Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography (English)

1 reference

human subject research project

11 August 2017

0 references

1 reference

Fischman AJ

1

1 reference

11 August 2017

Livni E

2

1 reference

11 August 2017

Babich J

3

1 reference

11 August 2017

Alpert NM

4

1 reference

11 August 2017

Liu YY

5

1 reference

11 August 2017

Thom E

6

1 reference

11 August 2017

Cleeland R

7

1 reference

11 August 2017

Prosser BL

8

1 reference

11 August 2017

Correia JA

9

1 reference

11 August 2017

Strauss HW

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 1993

1 reference

Antimicrobial Agents and Chemotherapy

11 August 2017

1 reference

11 August 2017

37

1 reference

11 August 2017

10

1 reference

11 August 2017

2144-2152

1 reference

describes a project that uses

11 August 2017

positron emission tomography

1 reference

Pharmacokinetics of gyrase inhibitors, Part 1: Basic chemistry and gastrointestinal disposition.

inferred from title

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Determination of object contour from projections for attenuation correction in cranial positron emission tomography.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

In-vitro activity of fleroxacin compared with three other quinolones

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeys

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinolone.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

In vitro activity of fleroxacin and 14 other antimicrobials against slime- and non-slime-producing Staphylococcus epidermidis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Safety of fleroxacin coadministered with theophylline to young and elderly volunteers

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Bacteriological and clinical studies on fleroxacin in male gonococcal urethritis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Comparison of the effect of temafloxacin, ciprofloxacin, or placebo on cerebral blood flow, glucose, and oxygen metabolism in healthy subjects by means of positron emission tomography.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Susceptibility of Staphylococcus species and subspecies to fleroxacin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Fleroxacin clinical pharmacokinetics

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

In-vitro activity of fleroxacin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192242

Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue

24 September 2018

1 reference

12 December 2020

In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus

1 reference

12 December 2020

Performance characteristics of an eight-ring whole body PET scanner

1 reference

12 December 2020

Performance study of the PC-384 positron camera system for emission tomography of the brain

1 reference

12 December 2020

High-performance liquid chromatographic determination of 6,8-difluoro-1-(2-fluoroethyl)-1,4- dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid and its metabolites in laboratory animals

1 reference

12 December 2020

Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin

1 reference

12 December 2020

Liquid-chromatographic determination of fleroxacin in serum and urine

1 reference

12 December 2020

The penetration of fleroxacin into bronchial mucosa

1 reference

12 December 2020

Therapeutic effect of fleroxacin against experimental pneumonia in mice

1 reference

12 December 2020

Determination of the new fluoroquinolone fleroxacin and its N-demethyl and N-oxide metabolites in plasma and urine by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

An assessment of cerebral blood flow and metabolism after fleroxacin therapy

1 reference

12 December 2020

[A study on the treatment duration of an antibacterial agent in complicated urinary tract infections. Utility and recurrence after 14-day treatment by fleroxacin]

1 reference

12 December 2020

Synthesis and biodistribution of 18F-labeled fleroxacin

1 reference

12 December 2020

The average density of healthy lung

1 reference

12 December 2020

Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers

1 reference

12 December 2020

Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers

1 reference

12 December 2020

Metabolism of fleroxacin in man

1 reference

12 December 2020

The metabolism and pharmacokinetics of fleroxacin in healthy subjects

1 reference

12 December 2020

Penetration of fleroxacin into maxillary sinus mucosa and palatine tonsil

1 reference

12 December 2020

Fleroxacin in the treatment of uncomplicated acute cystitis in women

1 reference

12 December 2020

Fleroxacin concentrations in myometrium, ovary and fallopian tube

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.37.10.2144

1 reference

11 August 2017

1 reference

11 August 2017

1 reference